{
    "pubmed_id": "34250512",
    "study_identifier": "PMID34250512_study-01",
    "study_name": "Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells",
    "publication_title": "Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells",
    "study_objective": "To evaluate COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses.",
    "study_description": "Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. Here, we evaluate 254 COVID-19 patients longitudinally up to 8 months and find durable broad-based immune responses. SARS-CoV-2 spike binding and neutralizing antibodies exhibit a bi-phasic decay with an extended half-life of >200 days suggesting the generation of longer-lived plasma cells. SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses. In addition, spike-specific IgG+ memory B cells persist, which bodes well for a rapid antibody response upon virus re-exposure or vaccination. Virus-specific CD4+ and CD8+ T cells are polyfunctional and maintained with an estimated half-life of 200 days. Interestingly, CD4+ T cell responses equally target several SARS-CoV-2 proteins, whereas the CD8+ T cell responses preferentially target the nucleoprotein, highlighting the potential importance of including the nucleoprotein in future vaccines. Taken together, these results suggest that broad and effective immunity may persist long-term in recovered COVID-19 patients.",
    "primary_institution_name": "Emory University",
    "study_personnel": [
        {
            "personnel_id": "PMID34250512_sanz",
            "honorific": "",
            "last_name": "Sanz",
            "first_name": "Ignacio",
            "suffixes": "",
            "organization": "Emory University",
            "orchid_id": "",
            "email": "ignacio.sanz@emory.edu",
            "seronet_title_in_study": "SeroNet Principal Investigator",
            "role_in_study": "Other",
            "site_name": "Emory University"
        },
        {
            "personnel_id": "PMID34250512_suthar",
            "honorific": "",
            "last_name": "Suthar",
            "first_name": "Mehul",
            "suffixes": "",
            "organization": "Emory University",
            "orchid_id": "",
            "email": "mehul.s.suthar@emory.edu",
            "seronet_title_in_study": "Investigator",
            "role_in_study": "Investigator",
            "site_name": "Emory University"
        }
    ],
    "study_file": [
        {
            "study_file_name": "Cell Reports Medicine serology and neut raw data_03032022.xlsx",
            "study_file_description": "Serology and Nerutral Raw data",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "mcelrath_cohort_covid_bcell_manuscript_export_13Sept2021.xlsx",
            "study_file_description": "Coivd B cell",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "mcelrath_cohort_covid_bcellModel_manuscript_export_17Sept2021.xlsx",
            "study_file_description": "Covid B cell model",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "mcelrath_cohort_covid_ics_manuscript_export_03Sept2021.xlsx",
            "study_file_description": "Covid Ics",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "mcelrath_cohort_covid_icsModel_manuscript_export_03Sept2021.xlsx",
            "study_file_description": "Covid Ics Model",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "mcelrath_cohort_covid_memModel_manuscript_export_03Sept2021.xlsx",
            "study_file_description": "Memory Cells",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "mcelrath_cohort_covid_memory_manuscript_export_03Sept2021.xlsx",
            "study_file_description": "Memory Cells",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "mmc1.pdf",
            "study_file_description": "Supplemental information",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "PMID34250512_v1.2.4.xlsm",
            "study_file_description": "Completed curation of the study into SeroNet Registry Template which includes SeroNet Study Descriptors.",
            "study_file_type": "Study Summary Description"
        }
    ],
    "study_link": [],
    "research_focus": "Immune Response",
    "study_type": "Serosurveillance",
    "keyword": [
        "B cells; CD4 T cells; CD8 T cells; COVID-19; SARS-CoV-2; binding antibody; coronaviruses; immune correlates; immune memory; neutralizing antibody"
    ],
    "clinical_study_design": "Longitudinal Study",
    "in_silico_model_type": "",
    "protocol": {
        "protocol_id": "PMID34250512_protocol-02",
        "protocol_file_name": "PMID34250512_protocol-02.txt",
        "protocol_name": "PMID34250512_protocol-02",
        "protocol_description": "Study Protocol",
        "protocol_type": "Study Protocol"
    },
    "reported_health_condition": [
        "Covid-19"
    ],
    "sars_cov_2_vaccine_type": [],
    "clinical_outcome_measure": "SARS-CoV-2 spike binding and neutralizing antibodies half-life, half-life of virus specific memory B-cells, half-life of virus specific CD4+ and CD8+ T-cells",
    "enrollment_start_date": "",
    "enrollment_end_date": "2020-10-01",
    "number_of_study_subjects": 110,
    "age_unit": "Years",
    "minimum_age": 18,
    "maximum_age": 82,
    "study_human_cohort": [
        {
            "arm_id": "PMID34250512_human_subject-01",
            "arm_name": "COVID-19 positive adults",
            "study_population_description": "COVID-19 positive adults (n = 254), Participants with a positive test prior to study enrollment or those diagnosed in study were asked to provide blood donation at approximately 7 days, 2 weeks, 1, 2, 3, 4, 6, 9- and 12-months post symptom onset",
            "arm_type": "Observational",
            "ethnicity": [
                "Hispanic or Latino",
                "Not Hispanic or Latino"
            ],
            "race": [
                "Other"
            ],
            "race_specify": [
                "Asian",
                "Black or African American",
                "White"
            ],
            "description": "",
            "sex_at_birth": [
                "Male I Female"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "GA",
                "WA"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [
                "Mild",
                "Moderate",
                "Severe"
            ],
            "post_covid_19_symptoms": [
                "Cough",
                "Shortness Of Breath",
                "Diarrhea",
                "Fever",
                "Headache",
                "Fatigue"
            ],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID34250512_human_subject-02",
            "arm_name": "Pre-pandemic controls",
            "study_population_description": "Pre-pandemic control (n = 51), samples were from recipients of either the seasonal inactivated influenza vaccine (n = 27, collected from 2014-2018) or the live yellow fever virus (YFV-17D) vaccine (n = 24, collected from 2005\u20132007)",
            "arm_type": "Negative Control",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Not Specified"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "GA"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Not Specified"
            ],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [
                "Not Specified"
            ],
            "post_covid_19_symptoms": [
                "Not Specified"
            ],
            "covid_19_complications": []
        }
    ],
    "study_model_cohort": [
        {
            "arm_id": "PMID34250512_organism_subject-01",
            "arm_name": "Vero E6 Cell lines",
            "study_population_description": "Vero E6 Cell lines",
            "arm_type": "Experimental Arm",
            "genus_and_species": [
                "African green monkey"
            ],
            "biosample_type": [
                "Cell Line"
            ],
            "strain_characteristics": [],
            "sex_at_birth": [
                "Other"
            ],
            "age_event": "Not Specified",
            "subject_phenotype": "",
            "study_location": [
                "Other"
            ],
            "sars_cov_2_history": [],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [],
            "post_covid_19_symptons": [],
            "covid_19_complications": []
        }
    ],
    "planned_visit": [
        {
            "visit_id": "PMID34250512_pv-01",
            "visit_name": "Cell lines, Vero E6",
            "visit_order_number": 1,
            "visit_min_start_day": 1,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-02",
            "visit_name": "Blood, serology",
            "visit_order_number": 2,
            "visit_min_start_day": 1,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-03",
            "visit_name": "Blood, serology",
            "visit_order_number": 3,
            "visit_min_start_day": 7,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-04",
            "visit_name": "Blood, serology",
            "visit_order_number": 4,
            "visit_min_start_day": 14,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-05",
            "visit_name": "Blood, PBMC",
            "visit_order_number": 5,
            "visit_min_start_day": 1,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-06",
            "visit_name": "Blood, PBMC",
            "visit_order_number": 6,
            "visit_min_start_day": 7,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-07",
            "visit_name": "Blood, PBMC",
            "visit_order_number": 7,
            "visit_min_start_day": 14,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-08",
            "visit_name": "Blood, serology",
            "visit_order_number": 8,
            "visit_min_start_day": 30,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-09",
            "visit_name": "Blood, serology",
            "visit_order_number": 9,
            "visit_min_start_day": 90,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-10",
            "visit_name": "Blood, serology",
            "visit_order_number": 10,
            "visit_min_start_day": 180,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-11",
            "visit_name": "Blood, serology",
            "visit_order_number": 11,
            "visit_min_start_day": 270,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-12",
            "visit_name": "Blood, serology",
            "visit_order_number": 12,
            "visit_min_start_day": 365,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-13",
            "visit_name": "Blood, PBMC",
            "visit_order_number": 13,
            "visit_min_start_day": 30,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-14",
            "visit_name": "Blood, PBMC",
            "visit_order_number": 14,
            "visit_min_start_day": 90,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-15",
            "visit_name": "Blood, PBMC",
            "visit_order_number": 15,
            "visit_min_start_day": 180,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-16",
            "visit_name": "Blood, PBMC",
            "visit_order_number": 16,
            "visit_min_start_day": 270,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID34250512_pv-17",
            "visit_name": "Blood, PBMC",
            "visit_order_number": 17,
            "visit_min_start_day": 365,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        }
    ],
    "experiment": [
        {
            "arm_id": [
                "PMID34250512_human_subject-01, PMID34250512_human_subject-02"
            ],
            "associated_first_planned_visit_id": [
                "PMID34250512_pv-02, PMID34250512_pv-03, PMID34250512_pv-04, PMID34250512_pv-05, PMID34250512_pv-06, PMID34250512_pv-07, PMID34250512_pv-08, PMID34250512_pv-09, PMID34250512_pv-10, PMID34250512_pv-11, PMID34250512_pv-12, PMID34250512_pv-13, PMID34250512_pv-14, PMID34250512_pv-15, PMID34250512_pv-16, PMID34250512_pv-17"
            ],
            "assay_type": "Neutralizing Antibody Titer Assay",
            "experiment_name": "Multiplex Bead Array Assay",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "serum",
                "blood"
            ],
            "biospecimen_collection_point": [
                "Post-symptom onset"
            ],
            "sars_cov_2_antigen": [
                "Full Length Spike Trimer",
                "N-terminal Domain (NTD)",
                "S1"
            ],
            "assay_use": "",
            "manufacture": "Mesoscale Discovery",
            "catalog_number": "",
            "virus_target": [
                "SARS-CoV-2"
            ],
            "antibody_isotype": [
                "IgA, IgM, IgG"
            ],
            "reporting_units": "AU",
            "assay_reporting_format": "Quantitative"
        },
        {
            "arm_id": [
                "PMID34250512_human_subject-01, PMID34250512_human_subject-02"
            ],
            "associated_first_planned_visit_id": [
                "PMID34250512_pv-02, PMID34250512_pv-03, PMID34250512_pv-04, PMID34250512_pv-05, PMID34250512_pv-06, PMID34250512_pv-07, PMID34250512_pv-08, PMID34250512_pv-09, PMID34250512_pv-10, PMID34250512_pv-11, PMID34250512_pv-12, PMID34250512_pv-13, PMID34250512_pv-14, PMID34250512_pv-15, PMID34250512_pv-16, PMID34250512_pv-17"
            ],
            "assay_type": "ELISPOT",
            "experiment_name": "Neutralizing Antibody Titer Assay",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "serum",
                "blood"
            ],
            "biospecimen_collection_point": [
                "Post-symptom onset"
            ],
            "sars_cov_2_antigen": [],
            "assay_use": "",
            "manufacture": "",
            "catalog_number": "",
            "virus_target": [],
            "antibody_isotype": [],
            "reporting_units": "",
            "assay_reporting_format": ""
        },
        {
            "arm_id": [
                "PMID34250512_human_subject-01, PMID34250512_human_subject-02"
            ],
            "associated_first_planned_visit_id": [
                "PMID34250512_pv-02, PMID34250512_pv-03, PMID34250512_pv-04, PMID34250512_pv-05, PMID34250512_pv-06, PMID34250512_pv-07, PMID34250512_pv-08, PMID34250512_pv-09, PMID34250512_pv-10, PMID34250512_pv-11, PMID34250512_pv-12, PMID34250512_pv-13, PMID34250512_pv-14, PMID34250512_pv-15, PMID34250512_pv-16, PMID34250512_pv-17"
            ],
            "assay_type": "Flow Cytometry",
            "experiment_name": "Spike and RBD memory B cell flow cytometry assays",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "serum",
                "blood"
            ],
            "biospecimen_collection_point": [
                "Post-symptom onset"
            ],
            "sars_cov_2_antigen": [
                "Full Length Spike Trimer",
                "Receptor Binding Domain (RBD)"
            ],
            "assay_use": "",
            "manufacture": "components from multiple manufacturers",
            "catalog_number": "",
            "virus_target": [
                "SARS-CoV-2"
            ],
            "antibody_isotype": [
                "IgA, IgM, IgG"
            ],
            "reporting_units": "",
            "assay_reporting_format": "Quantitative"
        }
    ],
    "geriatric_subjects": "Not Specified",
    "pediatric_subjects": "Not Specified",
    "pregnant_subjects": "Not Specified",
    "sars_cov_2_antibodies_measured": "Not Specified",
    "survey_instrument_shared": "Not Specified",
    "who_disease_severity_scale_used": "Not Specified",
    "inclusion_exclusion": [
        {
            "inclusion_exculusion_id": "PMID34250512_ie_02",
            "inclusion_criterion": "COVID-19 positive adults",
            "inclusion_criterion_category": "Inclusion"
        },
        {
            "inclusion_exculusion_id": "PMID34250512_ie_03",
            "inclusion_criterion": "Pediatric",
            "inclusion_criterion_category": "Exclusion"
        },
        {
            "inclusion_exculusion_id": "PMID34250512_ie_04",
            "inclusion_criterion": "immunocompromised",
            "inclusion_criterion_category": "Exclusion"
        },
        {
            "inclusion_exculusion_id": "PMID34250512_ie_05",
            "inclusion_criterion": "HIV positive",
            "inclusion_criterion_category": "Exclusion"
        },
        {
            "inclusion_exculusion_id": "PMID34250512_ie_06",
            "inclusion_criterion": "active hepatitis B or C virus infection",
            "inclusion_criterion_category": "Exclusion"
        },
        {
            "inclusion_exculusion_id": "PMID34250512_ie_07",
            "inclusion_criterion": "used immunosuppressive drugs for 2 weeks or more in the preceding 3 months",
            "inclusion_criterion_category": "Exclusion"
        },
        {
            "inclusion_exculusion_id": "PMID34250512_ie_08",
            "inclusion_criterion": "received blood products or immune globulin 42\u00a0days prior to enrollment",
            "inclusion_criterion_category": "Exclusion"
        },
        {
            "inclusion_exculusion_id": "PMID34250512_ie_09",
            "inclusion_criterion": "received convalescent COVID-19 plasma",
            "inclusion_criterion_category": "Exclusion"
        },
        {
            "inclusion_exculusion_id": "PMID34250512_ie_10",
            "inclusion_criterion": "pregnant",
            "inclusion_criterion_category": "Exclusion"
        },
        {
            "inclusion_exculusion_id": "PMID34250512_ie_11",
            "inclusion_criterion": "breast feeding",
            "inclusion_criterion_category": "Exclusion"
        }
    ]
}
